Multivalent Puromycin Linker for Higher-Diversity mRNA Display

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing display methods using puromycin-like substances can only conjugate one translation product to one nucleic acid, limiting the diversity and efficiency of peptide selection.

Innovation Solution

A linker with multiple puromycin-like substances is used to conjugate multiple translation products to a single mRNA, enabling efficient production of genetic information material-linker-peptide conjugates through repeated translation steps.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If a puromycin-like substance is used to conjugate translation products to nucleic acid, then the genotype-phenotype mapping is achieved, but only one translation product can be conjugated to one nucleic acid, limiting the diversity and efficiency of peptide selection

Engineering Contradiction:
Improveconjugation capacityVSAvoidpeptide selection efficiency
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The puromycin-like substance is divided into multiple functional units, each capable of independently conjugating a translation product to the nucleic acid. This segmentation allows multiple peptides to be attached to a single mRNA molecule, increasing both conjugation capacity and selection efficiency

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The modified puromycin-like substance serves multiple functions simultaneously: it acts as a substrate for peptidyl transfer reaction, a linker for conjugating multiple peptides, and a bridge connecting the phenotype (peptide) to the genotype (nucleic acid). This multi-functionality resolves the contradiction by enabling one molecule to conjugate multiple translation products

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Adaptability or versatility

If multiple translation products are conjugated to a single mRNA, then the diversity of peptide selection is improved, but the complexity of the conjugate structure increases

Engineering Contradiction:
Improvepeptide diversityVSAvoidconjugate structure
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The conjugate structure is segmented into modular units where each puromycin-like substance acts as an independent attachment point. This modular segmentation allows multiple peptides to be conjugated in a systematic way, managing structural complexity while maintaining high peptide diversity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The puromycin-like substance serves as an intermediary molecule that simplifies the complex conjugation process. It mediates between the ribosome (translation machinery) and the nucleic acid, providing a standardized interface for attaching multiple peptides without requiring complex direct conjugation mechanisms

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for multivalent interactions with target substances, enhancing the recovery of peptides with target binding ability and improving the efficiency of display methods.

Implementation Method 1

the puromycin-like substance is bonded to the C-terminus of the Elongating peptide chain as a substrate for a peptidyl transfer reaction on the ribosome

Methodology Applied
Scientific EffectPeptidyl transfer reaction: Chemical Bonding

Implementation Method 2

mRNA and a puromycin-like substance are bonded covalently using RNA ligase or non-covalently by hybridization of nucleic acids

Methodology Applied
Scientific EffectNucleic acid hybridization: Chemical Bonding

Data Source

PatentEP4707390A1linker
Publication Date: 2026.03.11 PEPTIDREAM INC
  • EP4707390A1 patent drawingFigure 1-1
  • EP4707390A1 patent drawingFigure 1-2
  • EP4707390A1 patent drawingFigure 1-3

AI summary

The present invention relates to a linker and use thereof. The linker of the present invention is a linker including: an attachment part having a structure that can be attached to a desired genetic information material; and at least two or more puromycin-like substances, wherein each of the puromycin-like substances can be covalently bonded to a C-terminus of a desired peptide.